F

Fulcrum Therapeutics

D
FULC
USD
0.015
(0.4298%)
Market Closed
24,310.00
حجم التداول
-0.15
الربح لكل سهم
-
العائد الربحي
-10.308824
P/E
218,714,698.85
حجم السوق
اليوم
0.4298%
1 اسبوع
9.020%
1 شهر
-0.849%
6 اشهر
-53.882%
12 اشهر
-15.644%
بداية السنة
-48.074%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
197
عدد التوصيات
3

Title:
Fulcrum Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
هل تحتاج مساعدة او لديك استفسار؟